SCHEMBL12822925

SCHEMBL12822925

CCCC(O)c1ccc(-c2ccc(OCc3ccc(-c4ccc(O)c(F)c4F)cc3)c(F)c2F)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 1/20 0.33
▸ FFAR1 O14842 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ GCGR P47871 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ ESR1 P03372 1/20 0.32
▸ ESR2 Q92731 1/20 0.32
▸ GABRA1 P14867 3/20 0.31
▸ GABRB2 P47870 3/20 0.31
▸ ALOX5 P09917 1/20 0.31
▸ FAAH O00519 1/20 0.31
▸ CYP3A4 P08684 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ PDE4A P27815 1/20 0.30
▸ PDE4B Q07343 1/20 0.30
▸ PDE4C Q08493 1/20 0.30
▸ PDE4D Q08499 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12823854 1.00 FFAR4 (0.33) FFAR4FFAR1MEN1KMT2AGCGR
SCHEMBL12821312 0.92 KMT2A (0.37) FFAR4FFAR1MEN1KMT2AKDM4E
SCHEMBL12822822 0.92 KMT2A (0.37) FFAR4FFAR1MEN1KMT2AKDM4E
SCHEMBL12821319 0.91 CYP17A1 (0.39) FFAR4FFAR1GCGRKDM4EMAPT
SCHEMBL10303195 0.90 FFAR1 (0.39) FFAR4FFAR1GCGRKDM4EMAPT
SCHEMBL10303161 0.90 FFAR4 (0.33) FFAR4KDM4EMAPTMAPK1GABRA1
SCHEMBL12823210 0.88 ABCB1 (0.38) FFAR4FFAR1ESR1ESR2FAAH
SCHEMBL12823598 0.86 FFAR1 (0.36) FFAR4FFAR1ESR1ESR2FAAH
SCHEMBL12716550 0.86 CYP17A1 (0.33) MEN1KMT2AKDM4EMAPTMAPK1
SCHEMBL13586388 0.85 FAAH (0.42) FFAR4FFAR1KDM4EMAPTFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110090450-A1 FOUR-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2011-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110090450-A1 FOUR-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE LEF1, LAS1L, EFHD2 FFAR4 546/4885FFAR1 247/4885MEN1 2496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback